Thank You for 20 Years of Hope Through Research
Thank You for 20 Years of Hope Through Research
A special message from OCRF Founder and Chair, Sol Schreiber.
News
FDA Approves Genentech's Avastin Plus Chemotherapy to ...
FDA Approves Genentech's Avastin Plus Chemotherapy to Treat Women With Platinum-Resistant Recurrent Ovarian Cancer
Genentech, a member of the Roche Group today announced that the U.S. Food and Drug Administration (FDA) approved Avastin® (bevacizumab) in combination with chemotherapy for the treatment of women with … Continued
Bevacizumab Plus Fosbretabulin Improves Progression-Free Su...
Bevacizumab Plus Fosbretabulin Improves Progression-Free Survival in Ovarian Cancer Patients
The combination of the antiangiogenesis drug bevacizumab and the vascular-disrupting agent fosbretabulin is superior to bevacizumab alone in the treatment of recurrent ovarian, tubal, and peritoneal cancer, according to an … Continued
Amgen Ovarian Cancer Drug Fails to Improve Overall Survival
Amgen Ovarian Cancer Drug Fails to Improve Overall Survival
Amgen Inc said its experimental ovarian cancer drug did not show statistically significant improvement in overall survival rate in a late-stage trial. Patients given the drug, trebananib, along with a chemotherapy … Continued
Diet May Influence Ovarian Cancer Survival
Diet May Influence Ovarian Cancer Survival
According to a new study published in the Journal of the National Cancer Institute, a good diet before diagnosis is linked with lower mortality among ovarian cancer survivors. Researchers analyzed … Continued
Use of Intensive Medical Services for Ovarian Cancer Patien...
Use of Intensive Medical Services for Ovarian Cancer Patients at End of Life Increases Despite Rise in Use of Hospice
There have been widespread efforts to improve the quality of life of terminally ill patients. As more patients choose to spend their final days and weeks in hospice care rather … Continued
Telomere Length and Mortality Following An Ovarian Cancer D...
Telomere Length and Mortality Following An Ovarian Cancer Diagnosis
Telomeres are essential for the maintenance of chromosomal integrity. Telomere shortening leads to genomic instability, which is hypothesized to play a role in cancer development and prognosis. New data published … Continued
Detection of Gene Mutations in Tampons of Patients With Hig...
Detection of Gene Mutations in Tampons of Patients With High-Grade Serous Ovarian Cancer
(October 14, 2014) In a pilot study published in the journal Obstetrics & Gynecology, researchers detected DNA derived from tumor cells in the vaginas of 60% of patients with ovarian … Continued
Ovarian Cancer Oncogene Found in ‘Junk DNA’
Ovarian Cancer Oncogene Found in ‘Junk DNA’
(October 6, 2014) A research team based at the University of Pennsylvania mined junk DNA sequences to identify a non-protein-coding RNA whose expression is linked to ovarian cancer. The study, … Continued
SGO Perspectives on Endpoints for Studies of Ovarian Cancer
SGO Perspectives on Endpoints for Studies of Ovarian Cancer
(Sept. 29, 2014) In a perspective piece for the website MedPage Today, representatives from the Society of Gynecologic Oncology discuss clinical endpoints appropriate for studies addressing the “unique characteristics” of … Continued
Maintenance Pazopanib in Ovarian Cancer: No Survival Benefi...
Maintenance Pazopanib in Ovarian Cancer: No Survival Benefit, High Rate of Complications
(Sept. 25, 2014) Maintenance therapy with the oral agent pazopanib improved progression free survival (PFS) by a median of 5.6 months in patients with advanced ovarian cancer but did not … Continued
OCRF Research Finds Metastasis Promoted by Mesothelial Cells
OCRF Research Finds Metastasis Promoted by Mesothelial Cells
A new study in the Journal of Clinical Investigation indicates that mesothelial cells actively promote the spread of ovarian cancer. Using a three dimensional culture model of ovarian cancer metastasis, … Continued